Mesocellular oxide foams as hemostatic compositions and methods of use
US8603543B2 · kind B2 · utility
2Cited by
5References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 2, 2012 |
| Grant date | Dec 10, 2013 |
| Priority date | — |
| Expiry date | May 12, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2400/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to hemostatic compositions comprising a mesocellular oxide foam and, optionally, a biologically active agent such as a procoagulant, as well as devices and methods of use to promote blood clotting.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.